Загрузка...
HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
COVID-19 has attracted global attention due to its rapid spread around the world with substantial morbidity and associated mortality. Severe COVID-19 can be complicated by the acute respiratory distress syndrome, sepsis and septic shock leading to death. These complications are thought to result fro...
Сохранить в:
| Опубликовано в: : | Heliyon |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7720697/ https://ncbi.nlm.nih.gov/pubmed/33313438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2020.e05672 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|